AIM: To establish and characterize a spontaneously immortalized human dermal microvascular endothelial cell line, iHDME1. METHODS: We developed a spontaneous immortalization method. This approach is based on the application of optimized culture media and culture conditions without addition of any exogenous oncogenes or carcinogens. Using this approach, we have successfully established a microvascular endothelial cell line, iHDME1, from primary human dermal microvascular endothelial cells. iHDME1 cells have been maintained in culture dishes for more than 50 passages over a period of 6 mo. Using a GFP expressing retrovirus, we generated a GFP-stable cell line (iHDME1-GFP). RESULTS: iHDME1 retain endothelial morphology and uniformly express endothelial markers such as VEGF receptor 2 and VE-cadherin but not α-smooth muscle actin (α-SM-actin) and cytokeratin 18, markers for smooth muscle cells and epithelial cells respectively. These cells retain endothelial properties, migrate in response to VEGF stimulation and form 3-D vascular structures in Matrigel, similar to the parental cells. There is no significant difference in cell cycle profile between the parental cells and iHDME1 cells. Further analysis indicates enhanced stemness in iHDME1 cells compared to parental cells. iHDME1 cells display elevated expression of CD133 and hTERT. CONCLUSION: iHDME1 cells will be a valuable source for studying angiogenesis.
AIM: To establish and characterize a spontaneously immortalized human dermal microvascular endothelial cell line, iHDME1. METHODS: We developed a spontaneous immortalization method. This approach is based on the application of optimized culture media and culture conditions without addition of any exogenous oncogenes or carcinogens. Using this approach, we have successfully established a microvascular endothelial cell line, iHDME1, from primary human dermal microvascular endothelial cells. iHDME1 cells have been maintained in culture dishes for more than 50 passages over a period of 6 mo. Using a GFP expressing retrovirus, we generated a GFP-stable cell line (iHDME1-GFP). RESULTS: iHDME1 retain endothelial morphology and uniformly express endothelial markers such as VEGF receptor 2 and VE-cadherin but not α-smooth muscle actin (α-SM-actin) and cytokeratin 18, markers for smooth muscle cells and epithelial cells respectively. These cells retain endothelial properties, migrate in response to VEGF stimulation and form 3-D vascular structures in Matrigel, similar to the parental cells. There is no significant difference in cell cycle profile between the parental cells and iHDME1 cells. Further analysis indicates enhanced stemness in iHDME1 cells compared to parental cells. iHDME1 cells display elevated expression of CD133 and hTERT. CONCLUSION: iHDME1 cells will be a valuable source for studying angiogenesis.
Authors: B L Allen-Hoffmann; S J Schlosser; C A Ivarie; C A Sattler; L F Meisner; S L O'Connor Journal: J Invest Dermatol Date: 2000-03 Impact factor: 8.551
Authors: E W Ades; F J Candal; R A Swerlick; V G George; S Summers; D C Bosse; T J Lawley Journal: J Invest Dermatol Date: 1992-12 Impact factor: 8.551
Authors: H D Soule; T M Maloney; S R Wolman; W D Peterson; R Brenz; C M McGrath; J Russo; R J Pauley; R F Jones; S C Brooks Journal: Cancer Res Date: 1990-09-15 Impact factor: 12.701
Authors: Ming Jiang; Douglas W Strand; Suzanne Fernandez; Yue He; Yajun Yi; Andreas Birbach; Qingchao Qiu; Johannes Schmid; Dean G Tang; Simon W Hayward Journal: Stem Cells Date: 2010-02 Impact factor: 6.277
Authors: Antonio A Sinisi; Paolo Chieffi; Daniela Pasquali; Annamaria Kisslinger; Stefania Staibano; Antonio Bellastella; Donatella Tramontano Journal: In Vitro Cell Dev Biol Anim Date: 2002-03 Impact factor: 2.416
Authors: Irina Zakharova; Shoraan Saaya; Alexander Shevchenko; Alena Stupnikova; Maria Zhiven'; Pavel Laktionov; Alena Stepanova; Alexander Romashchenko; Lyudmila Yanshole; Alexander Chernonosov; Alexander Volkov; Elena Kizilova; Evgenii Zavjalov; Alexander Chernyavsky; Alexander Romanov; Andrey Karpenko; Suren Zakian Journal: Front Bioeng Biotechnol Date: 2022-03-11
Authors: Diandra K Smith; Sarrah L Hasanali; Jiaojiao Wang; Georgios Kallifatidis; Daley S Morera; Andre R Jordan; Martha K Terris; Zachary Klaassen; Roni Bollag; Vinata B Lokeshwar; Bal L Lokeshwar Journal: Prostate Date: 2020-06-16 Impact factor: 4.104